⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28666453 | 0.78 | — | — | |
| SCHEMBL377874 | 0.78 | — | — | |
| Fluoride SCHEMBL28365973 | 0.75 | — | — | |
| SCHEMBL6260350 | 0.73 | CES2 (0.32) | — | |
| SCHEMBL28671390 | 0.73 | TSHR (0.35) | — | |
| SCHEMBL9140820 | 0.73 | — | — | |
| SCHEMBL2406044 | 0.73 | — | — | |
| SCHEMBL9418541 | 0.73 | — | — | |
| SCHEMBL10172169 | 0.73 | — | — | |
| SCHEMBL29788369 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4721152-A2 | ORGANIC THIN FILM COATINGS FOR BATTERY MATERIALS | Coreshell Technologies, Inc. (US) | 2026-04-08 | — | — | EP | claimed |
| CN-119528724-A | Synthesis method of ethyl 3, 3-trifluoropropionate | 淄博飞源化工有限公司 | 2025-02-28 | — | — | CN | claimed |
| WO-2024249841-A2 | ORGANIC THIN FILM COATINGS FOR BATTERY MATERIALS | CORESHELL TECHNOLOGIES, INC. (US) | 2024-12-05 | — | — | WO | claimed |
| CN-116751122-A | Method for preparing 4, 4-trifluoro butyric acid | 山东华安新材料有限公司 | 2023-09-15 | — | — | CN | claimed |
| CN-115677982-A | PH response type epoxy resin curing agent and preparation method and application thereof | 智仑超纯环氧树脂(西安)有限公司 | 2023-02-03 | — | — | CN | claimed |
| CN-114002256-A | Method for measuring trace hydroxyl value of modified polyphenylene oxide | 珠海宏昌电子材料有限公司 | 2022-02-01 | — | — | CN | claimed |
| CN-110540176-B | Method for improving purity of lithium bis (fluorosulfonyl) imide | 浙江蓝天环保高科技股份有限公司 | 2021-05-18 | — | — | CN | claimed |
| CN-110540176-A | Method for improving purity of lithium bis (fluorosulfonyl) imide | ZHEJIANG LANTIAN ENVIRONMENTAL PROT HI TECH CO LTD | 2019-12-06 | — | — | CN | claimed |
| EP-4721152-A2 | ORGANIC THIN FILM COATINGS FOR BATTERY MATERIALS | Coreshell Technologies, Inc. (US) | 2026-04-08 | — | — | EP | disclosed |
| CN-119528724-A | Synthesis method of ethyl 3, 3-trifluoropropionate | 淄博飞源化工有限公司 | 2025-02-28 | — | — | CN | disclosed |
| CN-119528710-A | 2, 3-Disubstituted naphthoquinone compound, application and preparation method thereof | 中国农业科学院兰州畜牧与兽药研究所 | 2025-02-28 | — | — | CN | disclosed |
| WO-2024249841-A2 | ORGANIC THIN FILM COATINGS FOR BATTERY MATERIALS | CORESHELL TECHNOLOGIES, INC. (US) | 2024-12-05 | — | — | WO | disclosed |
| CN-118852188-A | Cepharanthine derivative, preparation method and medical application thereof | 北京化工大学 | 2024-10-29 | — | — | CN | disclosed |
| CN-115611959-B | Avermectin B2aDerivative, preparation method and application thereof | 河北威远生物化工有限公司 | 2024-10-11 | — | — | CN | disclosed |
| EP-1940406-A2 | POTASSIUM CHANNEL INHIBITORS | Merck and Co., Inc. (US) | 2008-07-09 | — | — | EP | disclosed |
| WO-2008076562-A1 | 5- [4- (AZETIDIN-3-YL0XY) -PHENYL] -2-PHENYL-5H-THIAZ0L0 [5,4-C] PYRIDIN-4-0NE DERIVATIVES AND THEIR USE AS MCH RECEPTOR ANTAGONISTS | ELI LILLY AND COMPANY (US) | 2008-06-26 | — | — | WO | disclosed |
| US-7276511-B2 | Benzylamine derivative | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2007-10-02 | — | — | US | disclosed |
| WO-2007050348-A2 | POTASSIUM CHANNEL INHIBITORS | MERCK & CO., INC. (US) | 2007-05-03 | — | — | WO | disclosed |
| US-20060194841-A1 | E.g., N-{2-(3,4-dichlorophenyl)-2-[(3,3-diphenylpropionyl)-methylamino]-4-{spiro[benzo(c)thiophene-1(3H),4'-piperidine]-(2S)-oxide}-1'-yl-butyl}-3,3,3-trifluoro-N-methyl-propionamide hydrochloride, NK-1 or NK-2 receptor antagonists; irritable bowel syndrome, pain, anxiety, COPD, headaches and vomiting | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2006-08-31 | — | — | US | disclosed |
| EP-1650189-A1 | BENZYLAMINE DERIVATIVE | Zeria Pharmaceutical Co., Ltd. (JP) | 2006-04-26 | — | — | EP | disclosed |